Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fusion Antibody (FAB)

Price 3.75p on 29-03-2024 at 04:45:09
Change 0.00p 0%
Buy 3.80p
Sell 3.70p
Buy / Sell FAB Shares
Last Trade: Buy 34.00 at 3.80p
Day's Volume: 0
Last Close: 3.75p
Open: 0.00p
ISIN: GB00BDQZGK16
Day's Range 0.00p - 0.00p
52wk Range: 3.10p - 50.00p
Market Capitalisation: £4m
VWAP: 0.00p
Shares in Issue: 95m

Recent Trades History Fusion Antibody (FAB)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 34 3.80p Ordinary
16:29:48 - 28-Mar-24
Buy* 26 3.80p Ordinary
16:28:09 - 28-Mar-24
Sell* 7,500 3.702p Ordinary
16:13:44 - 28-Mar-24
Sell* 5,600 3.702p Ordinary
16:12:42 - 28-Mar-24
Buy* 76 3.90p SI Trade
15:40:23 - 28-Mar-24
Unknown* 10,000 3.80p Ordinary
15:03:31 - 28-Mar-24
Buy* 25 3.90p SI Trade
15:03:24 - 28-Mar-24
Buy* 103 3.878p Ordinary
12:29:22 - 28-Mar-24
Buy* 51 3.878p Ordinary
12:26:46 - 28-Mar-24
Buy* 51 3.878p Ordinary
12:26:14 - 28-Mar-24

Share Price History for Fusion Antibody

Time period:
to
Date Open High Low Close Volume

Share News for Fusion Antibody

TRADING UPDATES: Sondrel wins USD23 million contract

27th Feb 2024 14:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

14th Feb 2024 11:27

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management. Read More

Fusion Antibodies strikes follow-on research and development project

6th Feb 2024 11:48

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company". Read More

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

6th Feb 2024 10:05

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

1st Feb 2024 12:00

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics. Read More

FTSE 100 Latest
Value7,952.62
Change0.00

Login to your account

Forgot Password?

Not Registered